- Reliable detection of infectious diseases within minutes.
- Increases throughput over other molecular platforms by reducing amplification time.
- Leverages current molecular laboratory operations.
Not all products are available in all countries and regions. Please check with your local LumiraDx sales representative or distributor for availability in specific markets. LumiraDx SARS-CoV-2 RNA STAR is available in the US under FDA Emergency Use Authorization.
LumiraDx SARS-CoV-2 RNA STAR Complete is currently under review by the Food and Drug Administration (FDA) for Emergency Use Authorization. LumiraDx SARS-CoV-2 RNA STAR Complete is being distributed in accordance with Section IV.C. of FDA’s “Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency – Immediately in Effect Guidance for Clinical Laboratories, Commercial Manufacturers, and Food and Administration Staff” (Issued May 11, 2020). read FDA guidance